Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00296972
Recruitment Status : Terminated (not funded)
First Posted : February 27, 2006
Last Update Posted : April 23, 2007
Hoffmann-La Roche
Information provided by:
University Health Network, Toronto

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Study Completion Date : April 2007